Cargando…

Innovative oncology products: time to revisit the strategy development?

Detalles Bibliográficos
Autor principal: Krendyukov, Andriy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830456/
https://www.ncbi.nlm.nih.gov/pubmed/31749992
http://dx.doi.org/10.1136/esmoopen-2019-000571
_version_ 1783465779508805632
author Krendyukov, Andriy
author_facet Krendyukov, Andriy
author_sort Krendyukov, Andriy
collection PubMed
description
format Online
Article
Text
id pubmed-6830456
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-68304562019-11-20 Innovative oncology products: time to revisit the strategy development? Krendyukov, Andriy ESMO Open Editorial BMJ Publishing Group 2019-10-25 /pmc/articles/PMC6830456/ /pubmed/31749992 http://dx.doi.org/10.1136/esmoopen-2019-000571 Text en © Author (s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ on behalf of the European Society for Medical Oncology. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, any changes made are indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Editorial
Krendyukov, Andriy
Innovative oncology products: time to revisit the strategy development?
title Innovative oncology products: time to revisit the strategy development?
title_full Innovative oncology products: time to revisit the strategy development?
title_fullStr Innovative oncology products: time to revisit the strategy development?
title_full_unstemmed Innovative oncology products: time to revisit the strategy development?
title_short Innovative oncology products: time to revisit the strategy development?
title_sort innovative oncology products: time to revisit the strategy development?
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830456/
https://www.ncbi.nlm.nih.gov/pubmed/31749992
http://dx.doi.org/10.1136/esmoopen-2019-000571
work_keys_str_mv AT krendyukovandriy innovativeoncologyproductstimetorevisitthestrategydevelopment